Cancer Therapy Fairbanks AK

Cancer can affect every part of the body. Cancer treatment varies widely and may include anti-cancer drugs, radiation therapy, chemotherapy, surgery, biological therapies, bone marrow transplantations, targeted cancer therapies, and others. See below to learn more and to gain access to oncologists in Fairbanks, AK who provide cancer therapy.

William A Cox
(907) 452-4768
1640 Cowles St
Suite 1, AK
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Essam Darwish Shihadeh, MD
(907) 458-5380
1640 Cowles St Ste 2
Fairbanks, AK
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Arabian Gulf Univ, Coll Of Med And Med Sci, Manama, Bahrain
Graduation Year: 1992

Data Provided by:
Jack Michae Carroll
(907) 452-4768
1640 Cowles St
Fairbanks, AK
Specialty
Hematology / Oncology

Data Provided by:
Alexander D Colevas, MD
(617) 632-2205
Fairbanks, AK
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Johns Hopkins Univ Sch Of Med, Baltimore Md 21205
Graduation Year: 1989

Data Provided by:
Essam Shihadeh
(907) 458-5380
Fairbanks, AK
Specialty
Radiation Oncology
Associated Hospitals
Fairbanks Cancer Treatmt Ctr

Jack Michael Carroll, MD
(907) 452-4768
1640 Cowles St Ste 1
Fairbanks, AK
Specialties
Internal Medicine, Medical Oncology
Gender
Male
Education
Medical School: Or Hlth Sci Univ Sch Of Med, Portland Or 97201
Graduation Year: 1969
Hospital
Hospital: Fairbanks Mem Hosp/Denali Ctr, Fairbanks, Ak

Data Provided by:
Dr.Essam Shihadeh
(907) 458-5380
1640 Cowles St # 2
Fairbanks, AK
Gender
M
Education
Medical School: Arabian Gulf Univ, Coll Of Med And Med Sci, Manama
Year of Graduation: 1992
Speciality
Oncologist
General Information
Accepting New Patients: Yes
RateMD Rating
1.0, out of 5 based on 1, reviews.

Data Provided by:
Jacqueline Ann Cox
(907) 452-4768
1640 Cowles St
Fairbanks, AK
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
J. Carroll
1640 Cowles St Ste 1
Fairbanks, AK
Associated Hospitals
J Michael Carroll

Alexander Colevas
(617) 632-2205
Fairbanks, AK
Specialty
Hematology-Oncology

Data Provided by:

Female Dangers

While breast cancer is the biggest and most publicized cancer threat American
women face, it is not the only female-specific cancer. Cervical, ovarian and uterine
malignancies affect thousands each year. Learn what to look out for so you don’t fall victim.

By Lisa James

May 2006

If someone says the words “female” and “cancer” to you, the first word that probably pops into your head is “breast.” After all, the numbers are hard to ignore: Almost 213,000 American women develop breast malignancies each year…and more than 40,000 die from them.

But a woman overlooks her reproductive tract at her peril; just ask actress Fran Drescher, who graced the cover of last year’s Annual ET Cancer Issue. In her book, Cancer Schmancer (Warner Books), Drescher explains how she saw nine doctors—count ’em, nine—before her uterine cancer was finally discovered and treated, leaving her unable to bear children. “Women need to understand gynecological cancers and the tests that can help detect them,” she writes. “We have to…become educated consumers, network among ourselves, and gain information and insight into getting diagnosed and getting treatment. Someone gimme a podium!”

Taking our lead from “The Nanny,” ET presents what you need to know about three cancers—cervical, ovarian and uterine—that should be on every woman’s radar. (Statistics given are 2006 estimates from the American Cancer Society [ACS].)

Uterine Cancer: A Hormonal Challenge

What it is: Most are endometrial cancers; they arise in the inner lining (endometrium) of the uterus, the part that grows and is shed over the course of a woman’s menstrual cycle. Tumors called sarcomas can develop in the muscle tissue, but account for only 2% to 4% of all uterine cancers.
Number of women affected: 41,200 cases of endometrial cancer (the most common reproductive-tract malignancy) and 7,350 deaths. It is one of the more treatable cancers though, with a five-year survival rate of 84%.

At greatest risk: Roughly 70% of all women affected are between the ages of 45 and 74. Endometrial cancer shares a lot of risk factors with ovarian cancer because excessive estrogen exposure promotes overgrowth of the uterine lining. Taking the drug tamoxifen for breast cancer also increases risk, as does having undergone pelvic radiation therapy. Genetic history is another factor, particularly in families affected by hereditary nonpolyposis colon cancer (HNPCC).

The symptoms: Abnormal bleeding, especially after menopause. Pain and weight loss can be signs of late-stage disease.

The tests: There are no standard screening tests for this kind of cancer. Abnormal bleeding may prompt your doctor to perform an endometrial biopsy, in which a thin needle is passed through the cervical opening to collect cells in the uterine lining.

Vital info: Try your best to drop those extra pounds. Obesity ups the risk of hormonally driven cancers because fat tissue can transform other hormones into estr...

Click here to read the rest of this article from Energy Times